Study of HB05P for muscle health in older adults
Part of Brain & nervous system clinical trials.
This study tests a food product called HB05P to see if it can help improve muscle strength and physical function in people with low muscle mass. It includes a supervised exercise program and may help you maintain independence as you age.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 79 years old.
- You have been diagnosed with low muscle mass (sarcopenia) or are at risk for it.
- You have not been doing regular resistance exercise (like weight training) 2 or more times a week for the past 3 months.
- You are able to take part in a supervised exercise program at least 3 times a week.
- You have not had recent weight loss, fractures, or major health events like a heart attack or stroke in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a structured exercise and nutrition program can improve muscle health in older adults with (pre)sarcopenia, especially those who may have slower walking or reduced strength. It also checks safety by excluding people with unstable health problems and several specific medical conditions.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
This study tests whether a daily supplement called HMB (a natural substance found in some foods) can help improve walking and strength in people with sarcopenia (age-related muscle loss) who have recently spent time in bed. If you are between 50 and 99 years old and have weak muscles, this trial might help you regain function.
This trial tests whether adding protein powder to a resistance exercise program can improve muscle strength and mobility in people with sarcopenia, a condition of age-related muscle loss. It is designed for adults aged 35–75 who have low muscle strength and slow walking speed or other physical performance issues.
This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.
This study tests a new capsule called TJ0113 to see if it can help older adults with sarcopenia (muscle loss) improve their muscle strength and physical function. It's a phase 2 study, meaning the drug is being tested for safety and effectiveness.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.